Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5469-69-2

Post Buying Request

5469-69-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5469-69-2 Usage

Chemical Properties

Brown Solid

Check Digit Verification of cas no

The CAS Registry Mumber 5469-69-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,6 and 9 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 5469-69:
(6*5)+(5*4)+(4*6)+(3*9)+(2*6)+(1*9)=122
122 % 10 = 2
So 5469-69-2 is a valid CAS Registry Number.
InChI:InChI=1/C4H4ClN3/c5-3-1-2-4(6)8-7-3/h1-2H,(H2,6,8)

5469-69-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A10185)  3-Amino-6-chloropyridazine, 98%   

  • 5469-69-2

  • 1g

  • 229.0CNY

  • Detail
  • Alfa Aesar

  • (A10185)  3-Amino-6-chloropyridazine, 98%   

  • 5469-69-2

  • 5g

  • 945.0CNY

  • Detail
  • Alfa Aesar

  • (A10185)  3-Amino-6-chloropyridazine, 98%   

  • 5469-69-2

  • 25g

  • 4140.0CNY

  • Detail
  • Aldrich

  • (759430)  3-Amino-6-chloropyridazine  97%

  • 5469-69-2

  • 759430-1G

  • 99.45CNY

  • Detail
  • Aldrich

  • (759430)  3-Amino-6-chloropyridazine  97%

  • 5469-69-2

  • 759430-5G

  • 336.96CNY

  • Detail

5469-69-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Amino-6-chloropyridazine

1.2 Other means of identification

Product number -
Other names 6-Chloropyridazin-3-amine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5469-69-2 SDS

5469-69-2Relevant articles and documents

Synthesis and anti-proliferative activity studies of 2-(2-(trifluoromethyl)-6-(substituted)imidazo[1,2-b]pyridazin-3-yl)-N-(substituted)acetamide derivatives

Chavan, Sadhana L.,Chavan, Santosh L.,Gaikwad, Dattatraya D.,Pansare, Dattatraya N.,Pawar, Chandrakant D.,Pawar, Umakant D.,Shelke, Rohini N.,Zine, Ashok M.

, (2020)

A series of novel imidazo[1,2-b]pyridazin-3-yl acetamide derivatives (9a-9j) were synthesized from a 3,6-dichloropyridazine. We have developed a simple strategy for the synthesis of functionally diverse imidazole, and pyridiazine derivatives were reported via a series of steps. The work involves bicyclic imidazo-pyridazine ring formation, halogenation, cynation, hydrolysis, peptide coupling, and Buchwald reaction. The structure of the synthesized compounds was confirmed by IR, 1H NMR, 13C NMR,19F NMR, mass spectra, and elemental analysis, and purity is checked by HPLC. All synthesized compounds were screened for anticancer activity against A-549 and Du-145 cancer cell lines by MTT assay. The preliminary bioassay suggests that most of the compounds show anti-proliferation with different degrees; doxorubicin was used as positive control. The synthesized compound shows IC50 values in the range of 1.74μM to 16.17μM in both cell lines. The compounds 9e, 9g, and 9h were active compared with doxorubicin in both the cell lines. The compounds having cyclopentyl ring are active compared with higher and lower carbon analogues.

INHIBITORS OF LIN28 AND METHODS OF USE THEREOF

-

Page/Page column 52; 56; 89, (2021/06/26)

The present disclosure relates to compounds of formula (I) and compositions comprising the same. The disclosure further relates to methods of treating cancers.

Synthesis, characterization, and antidiabetic activity of 6-methoxyimidazo[1,2-b]pyridazine derivatives

Kota, Tata Veereswara Rao,Gandham, Himabindu,Sanasi, Paul Douglas

, p. 630 - 637 (2019/02/26)

The present article describes the synthesis, characterization, and antidiabetic activity of 6-methoxyimidazo[1,2-b]pyridazine derivatives 7a-l. The synthetic sequence for the preparation of these derivatives involves the following prominent reactions: (a) Step 1: involves the high-pressure amination reaction; (b) Step 2: involves the Zinc oxide nanoparticle-catalyzed cyclization reaction; (c) Step 3: involves the methoxylation; (d) Step 4: involves the bromination reaction; (e) Step 5: involves the Suzuki coupling reaction; (f) Step 6: involves the reduction of the –NO2 group; (g) Step 7: involves Boc protection of the 1o amino group (h) Step 8: involves diazotization of the amine group and finally the last of the synthesis (i) Step 9: involves the saponification of the ethyl ester group. Furthermore, the structures of the newly synthesized 6-methoxyimidazo[1,2-b]pyridazine derivatives 7a–l were determined using 1H NMR, 13C NMR, and Mass and IR spectroscopic analyses. These derivatives were evaluated for their antidiabetic property and the results revealed that most of the compounds exhibited significant potency. It is worth mentioning that compounds 7b (69.87%), 7f (69.0%), 7h (68.79%), and 7l (68.61%) with substitution R = para-NH2, para-COOH, meta-NH2, and meta-COOH, respectively, showed significant (good) hypoglycemic activity when compared to the standard drug insulin (50 mg/kg b.w) in reducing the blood glucose level.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5469-69-2